Search Results 1561-1570 of 17006 for monoclonal antibody

  1. A Study to Evaluate the Safety, PK/​PD of (OriCAR-017) in Subjects With RR/​MM - RIGEL Study - Mayo Clinic

    ... antibody (e.g., teclistamab), BCMA antibody directed conjugate (such as BLENREP), and BCMA-CAR-T (such as CARVYKT1TM); Subjects with adequate hematologic ...

  2. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

    Subjects with a positive test for Hepatitis C (HCV) antibody are excluded, regardless of viral load. If hepatitis C antibody is positive, confirmatory tests may ...

  3. A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa - Mayo Clinic

    ... antibodies, or positive result of Hep C polymerase chain reaction (PCR) analysis. The presence of COL7 antibodies in clinically significant titer by ...

  4. Pneumococcal 21-valent conjugate vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

    It works by causing your body to produce its own protection (antibodies) against the disease. Pneumococcal infection can cause serious problems, including ...

  5. Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome - Mayo Clinic

    - Absent or low patient donor-specific antibodies (DSA); - Mean fluorescence intensity (MFI) of any anti-donor HLA antibody by solid phase immunoassay ...

  6. A Study to Compare Standard-Dose Combination Chemotherapy with High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Resistant Germ Cell Tumors - Mayo Clinic

    Hepatitis C antibody. No late relapse with completely surgically resectable disease; Patients with late relapses defined as relapse ≥ 2 years from the date ...

  7. Oncology (Medical) - Clinical trials - Mayo Clinic

    The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

  8. OBINUTUZUMAB in Treatment of Fibrillary Glomerulonephritis - Mayo Clinic

    Secondary FGN (due to monoclonal gammopathy, autoimmune disease or malignancy). Presence of a secondary pathology on biopsy (e.g. diabetic nephropathy) ...

  9. Pediatrics Clinical Trials - Medical Professionals

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

  10. Efficacy and Safety of ISIS-TTR Rx in Familial Amyloid Polyneuropathy - Mayo Clinic

    Known monoclonal gammopathy of undetermined significance or multiple myeloma; Other causes of sensorimotor or autonomic neuropathy (e.g., autoimmune disease) ...